These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 25565674)
1. Effect of CYP2B6*6 on Steady-State Serum Concentrations of Bupropion and Hydroxybupropion in Psychiatric Patients: A Study Based on Therapeutic Drug Monitoring Data. Høiseth G; Haslemo T; Uthus LH; Molden E Ther Drug Monit; 2015 Oct; 37(5):589-93. PubMed ID: 25565674 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion. Kharasch ED; Lenze EJ Drug Metab Dispos; 2024 Apr; 52(5):455-466. PubMed ID: 38467432 [TBL] [Abstract][Full Text] [Related]
3. Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment. Kringen MK; Chalabianloo F; Bernard JP; Bramness JG; Molden E; Høiseth G Ther Drug Monit; 2017 Oct; 39(5):550-555. PubMed ID: 28723731 [TBL] [Abstract][Full Text] [Related]
4. Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta-analysis. Eum S; Sayre F; Lee AM; Stingl JC; Bishop JR Pharmacotherapy; 2022 Jan; 42(1):34-44. PubMed ID: 34752647 [TBL] [Abstract][Full Text] [Related]
5. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects. Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555 [TBL] [Abstract][Full Text] [Related]
6. Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6. Kirchheiner J; Klein C; Meineke I; Sasse J; Zanger UM; Mürdter TE; Roots I; Brockmöller J Pharmacogenetics; 2003 Oct; 13(10):619-26. PubMed ID: 14515060 [TBL] [Abstract][Full Text] [Related]
7. Impact of genetic variability in CYP2D6, CYP3A5, and ABCB1 on serum concentrations of quetiapine and N-desalkylquetiapine in psychiatric patients. Bakken GV; Molden E; Hermann M Ther Drug Monit; 2015 Apr; 37(2):256-61. PubMed ID: 25254417 [TBL] [Abstract][Full Text] [Related]
8. Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition. Kharasch ED; Crafford A Clin Pharmacol Ther; 2019 Jan; 105(1):142-152. PubMed ID: 29756345 [TBL] [Abstract][Full Text] [Related]
9. Does sex alter the relationship between CYP2B6 variation, hydroxybupropion concentration and bupropion-aided smoking cessation in African Americans? A moderated mediation analysis. Chenoweth MJ; Peng AR; Zhu AZX; Cox LS; Nollen NL; Ahluwalia JS; Benowitz NL; Knight J; Swardfager W; Tyndale RF Addiction; 2022 Jun; 117(6):1715-1724. PubMed ID: 34791718 [TBL] [Abstract][Full Text] [Related]
10. Impact of the CYP2D6 genotype on steady-state serum concentrations of aripiprazole and dehydroaripiprazole. Hendset M; Hermann M; Lunde H; Refsum H; Molden E Eur J Clin Pharmacol; 2007 Dec; 63(12):1147-51. PubMed ID: 17828532 [TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion. Laib AK; Brünen S; Pfeifer P; Vincent P; Hiemke C Ther Drug Monit; 2014 Aug; 36(4):473-9. PubMed ID: 24452068 [TBL] [Abstract][Full Text] [Related]
12. Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation. Fan L; Wang JC; Jiang F; Tan ZR; Chen Y; Li Q; Zhang W; Wang G; Lei HP; Hu DL; Wang D; Zhou HH Eur J Clin Pharmacol; 2009 Apr; 65(4):403-9. PubMed ID: 19066872 [TBL] [Abstract][Full Text] [Related]
13. Effects of Genetic Polymorphisms of CYP2B6 on the Pharmacokinetics of Bupropion and Hydroxybupropion in Healthy Chinese Subjects. Ma H; Zhang W; Yang X; Zhang Y; Wei S; Zhang H; Ma Y; Dang H Med Sci Monit; 2018 Apr; 24():2158-2163. PubMed ID: 29637923 [TBL] [Abstract][Full Text] [Related]
14. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity. Kharasch ED; Mitchell D; Coles R J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571 [TBL] [Abstract][Full Text] [Related]
15. Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation. Lv J; Hu L; Zhuo W; Zhang C; Zhou H; Fan L Pharmacogenet Genomics; 2016 Feb; 26(2):80-7. PubMed ID: 26580670 [TBL] [Abstract][Full Text] [Related]
16. The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity. Gao LC; Liu FQ; Yang L; Cheng L; Dai HY; Tao R; Cao SP; Wang D; Tang J Eur J Clin Pharmacol; 2016 Oct; 72(10):1205-1213. PubMed ID: 27439448 [TBL] [Abstract][Full Text] [Related]
17. Impact of Ageing on Serum Concentrations of Risperidone and Its Active Metabolite in Patients with Known CYP2D6 Genotype. Molden E; Waade RB; Hoff M; Haslemo T Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):470-475. PubMed ID: 27145399 [TBL] [Abstract][Full Text] [Related]
18. Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status. Gaebler AJ; Schneider KL; Stingl JC; Paulzen M Pharmacogenomics J; 2020 Dec; 20(6):840-844. PubMed ID: 32475982 [TBL] [Abstract][Full Text] [Related]
19. Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate. Gao L; He Y; Tang J; Yin J; Huang Z; Liu F; Ouyang D; Chen X; Zhang W; Liu Z; Zhou H PLoS One; 2013; 8(6):e62489. PubMed ID: 23840296 [TBL] [Abstract][Full Text] [Related]